Description: The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Home Page: www.proshares.com/funds/bib.html
BIB Technical AnalysisExchange: NASDAQ
Country: US
Currency: US Dollar ($)
Category: Trading--Leveraged Equity
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 177.45 | 0.00 | 177.45 |
| Stock non-US | 22.58 | 0.00 | 22.58 |
| Other | 20.85 | 0.00 | 20.85 |
| Cash | 0.00 | 120.88 | -120.88 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| United Kingdom | 4.06 | 0.35 |
| Japan | 0.00 | 0.01 |
| Australasia | 0.00 | 0.19 |
| Asia Emerging | 0.00 | 2.04 |
| Latin America | 0.00 | 0.34 |
| North America | 0.00 | 94.18 |
| Asia Developed | 0.00 | 1.00 |
| Europe Emerging | 0.00 | 0.03 |
| Europe Developed | 0.00 | 1.76 |
| Africa/Middle East | 0.00 | 0.11 |